top left cornertop right corner
Blackburn with Darwen Primary Care Trust - About Us
.

Medicines Management in the East Lancashire Health Economy

self care week

Self Care Week 2014 takes place from 17th – 23rd November.

The theme is ‘Self Care for Life – Be Healthy this Winter’ 

Click here to access the Forum and resources

 

Information on this website has been provided by the East Lancashire Medicines Management Board which oversees Medicines Management issues across the East Lancashire Health Economy (population 522,000), which consists of;

 

 

The Medicines Management Board (MMB)  consists of physicians and representatives of other key decision-makers in the use of medicines in primary and secondary care. The remit of this board is to review selected pharmaceutical products to assess their clinical value, safety and suitability for use in the East Lancashire Health Economy, and to guide all prescribers in primary and secondary care in using them appropriately.

 

Typical drugs that are considered include newly licensed drugs or those that have a new indication and drugs used to treat conditions with which primary care prescribers may be less familiar. Unlicensed drugs and individual requests are also considered. Requests for drugs to be reviewed may be made by any health care professional in the East Lancashire Health Economy.

The recommendations of the MMB and the evidence considered in the evaluations are summarised in the New Drug Reviews. When use with a shared care agreement is recommended for a particular drug an effective Shared Care Agreement is provided for local use. These documents are available on the website under " New Drug Reviews ” and “ Shared Care Protocols ” respectively.  

 

Any decisions on drug use are also included into the Joint Medicines Formulary, which acts as a

reference to medicines approved for use in East Lancashire.  The Joint Medicines Formulary is formatted in the same style of the BNF, and provides all prescribers with a defined list of medicines that are available to prescribe, as well as the traffic light recommendation for each and any other recommendations for their use.  The Joint Medicines Formulary is available on the website under the “ Medicines Formulary ” heading above. Within East Lancashire a Joint Wound Care Formulary has also been developed, which forms the basis for the prescribing of cost effective and evaluated wound care products, as well as giving guidance on selection of dressing, specialist products, and available sizes.  It is available on the website under the " Wound Care Formulary " heading above.

 

The MMB also provides supporting information on some general prescribing issues (e.g. product withdrawals) as well as ratifying prescribing and clinical guidelines, treatment protocols and integrated care pathways for use across East Lancashire, all of which can be found above under  "Guidelines ".

 

Latest decisions of the MMB are listed on the MMB website update email that is sent out each month.  Health care professionals in East Lancashire can also register to receive this and other news by clicking on the link at the top of the page.  Planned activities and other relevant news items can be found in our monthly newsletter  INTERFACE that is distributed to all healthcare professionals across East Lancashire and is also available online under the heading “ Newsletters & Minutes ” on the left hand navigation panel.

 

For Freedom of Information Requests, please contact:

foi@bwd.nhs.uk – NHS Blackburn with Darwen

foi@eastlancspct.nhs.uk – NHS East Lancashire

 

This website only uses essential, non-intrusive cookies, which are removed from your computer once you've left.

Click here to learn more about cookies.

 

 

Latest Updates by Section

INTERFACE - Latest Edition

NICE Bites - Latest Edition

 

MHRA Drug Safety Update -

Latest Edition

 

Drug Alerts and Withdrawals

 

18th November 2014

 

MHRA company led drug alert - Recivit Sublingual Tablets


 

Newletters and minutes

 

18th November 2014

 

MHRA Drug Safety Update - latest ition


 

Medicines Specific Guidleines

 

6th November 2014

 

Lipid Modification - Flow Chart


Newletters and Minutes

 

5th November 2014

 

NICE Bites - latest edition


Other Clinical Guidelines

 

5th November 2014

 

Gluten Free Foods Prescribing Guideline


Disease and condition specific guidelines

 

5th November 2014

 

NICEFLEX AntiTNFα in RA Pathways


 

Medicines Specific Guidlelines

 

4th November 2014

 

Guideline for Vitamin D in Children ELHT


Drug alerts and withdrawals

 

4th November 2014

 

Class 2 medicines recall - Zovirax eye ointment


 

Newletters and minutes

 

31st October 2014

 

Medicines Management Board Minutes September 2014


 

 Newletters and minutes

 

16th October 2014

 

Drug Safety Update - latest edition


Shared Care Guidelines

 

10th October 2014

 

Methotrexate SCG

Penicillamine SCG

Leflunomide SCG

Sodium Aurothiomalate SCG

Sulfasalazine SCG

Ciclosporin SCG

Azathioprine and Mercaptopurine SCG


Formulary updates

 

8th October 2014

 

Enazalutamide NICE TA316

RED Traffic Light

 

Lubiprostone NICE TA318

RED Traffic Light

 

Iplimumab NICE TA319

RED Traffic Light

 

Diethyl Fumarate NICE TA320

RED Traffic Light


Patient Group Directions

 

6th October 2014

 

Menigococcal B (Bexsero®▼)


Newsletters and Minutes

 

6th October 2014

 

NICE BITES - latest edition - Chronic Kidney Disease


Newsletters and Minutes

 

30th September 2014

 

Drug Safety Update - latest edition


Drug Alerts and Withdrawals

 

8th September 2014

 

Class 2 medicines recall - Motilium 10 and Motilium orodispersible tablets - McNeill products


Newsletters and Minutes

 

4th September 2014

 

Latest edition -NICE Bites August 2014


 

Drug Alerts and Withdrawals

 

13th August 2014

 

Class 2 medicines recall

 

Idarubicin 1mg/ml injection 5 & 10 ml manufactured by Teva UK Limited


Newsletters and Minutes

 

11th August 2014

 

Latest MHRA Drug Safety Update


Drug Alerts and Withdrawals

 

8th August 2014

 

Company-led drug recall: Triomel TPN products - Baxter Healthcare Ltd


Drug Alerts and Withdrawals

 

7th August 2014

 

Company-led drug recall: Baxter Compounded Parenteral Nutritional Products


Newsletters and Minutes

 

6th August 2014

 

Latest edition -NICE Bites July 2014


 

Drug Alerts and Withdrawals

 

29th July 2014

 

Company led  drug recall: Leflunomide medac 20mg f/c tablets (medac GmbH)


 

Drug Alerts and Withdrawals

 

28th July 2014

 

Class 2 medicines Recall - Buccolam Oromucosal Solution


Patient Group Directions

 

28th July 2014

 

Men ACWY Vaccine PGD (1.8.14)

 

Conjugate Men ACWY Advisory Information


 

Patient Group Directions

 

28th July 2014

 

Tickborne encephalitis PGD (1.8.14)

 

Tickborne Encephalitis Advisory Information

 


 

Patient Group Directions

 

28th July 2014

 

Mump, Measles & Rubella vaccine PGD (1.8.14)


 

Patient Group Directions

 

28th July 2014

 

Typhoid Vaccine PGD (1.8.14)

 


 

Palliative Care

 

28th July 2014

 

Palliative Care Prescribing Guidelines


Shared Care Guidelines

 

23rd July 2014

 

Memantine Shared Care Guideline


Shared Care Guidelines

 

23rd July 2014

 

Donepezil, Galantamine, Rivastigmine Shared Care Guideline


Newsletters and Minutes

 

22nd July 2014

 

Latest MHRA Drug Safety Update


 

MHRA - E-learning modules

 

22nd July 2014

 

E-learning modules on adverse drug reactions


 

Drug Alerts and Withdrawals

 

22nd July 2014

 

Class 2 medicines recall: amoxycillin sodium 500mg powder for solution for injection


 

Drug Alerts and Withdrawals

 

21st July 2014

 

Class 2 medicines recall: Midazolam Buccal Liquid 10mg/1ml, 5ml (Penn Pharma)


 

 

 

Richard Lee, East Lancashire Health Economy New Drugs Pharmacist.

Email: Interface@bwd.nhs.uk

Powered by EasySite™ Content Management System